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Summary
Objective: The current study determined the unconﬁned compressive modulus of tissue-engineered constructs with varying sulfated glycos-
aminoglycan (GAG) density produced by goat articular chondrocytes in type II collagen scaffolds prepared with a range of cross-link densities
and various times in culture. The purpose of this work is to establish a basis for future studies employing constructs of selected maturity (e.g.,
25%, 50%, or 75% normal GAG content) for cartilage repair in vivo.
Methods: Porous scaffolds (8 mm diameter by 2 mm thick) were fabricated from porcine type II collagen by freeze-drying, followed by dehy-
drothermal treatment and carbodiimide cross-linking. In a pilot study, passage 3 adult caprine articular chondrocytes isolated from one goat
were grown in scaffolds with six cross-link densities for 2, 3, 4, and 6 weeks (n¼ 3). The goal was to select scaffold cross-link densities and
times in culture that would produce constructs with approximately 25%, 50% and 75% the GAG density of native articular cartilage. Based on
the results of the pilot study, chondrocytes from three goats were grown in scaffolds with two cross-link densities for three time periods: 3, 5,
and 9 weeks (n¼ 6; one of the cross-link groups was run in quadruplicate). The equilibrium modulus from unconﬁned compression testing of
these samples was correlated with GAG content.
Results: There was a notable increase in GAG density with decreasing cross-link density. Histological analysis veriﬁed a chondrogenic pheno-
type and revealed various amounts of GAG and type II collagen-containing cartilage. The correlation between modulus and GAG density had
a linear coefﬁcient of determination of 0.60. One groupwith ameanGAG density of 22 mg/mm3, which was 140% theGAGdensity of normal cap-
rine articular cartilage, averaged a compressive modulus of 31.5 kPa, which was 10% of caprine articular cartilage tested in this study.
Conclusions: The GAG density and modulus of tissue-engineered constructs can be controlled by the degree of cross-linking of type II
collagen scaffolds and time in culture.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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One of the critical issues related to the implementation of
tissue engineering strategies for the treatment of a wide
array of problems relates to the degree to which the tissue-
engineered construct should be allowed to develop (i.e.,
mature) in vitro prior to implantation. For example, how
mature should a cartilaginous construct, produced in culture,
be before it is implanted into a defect in articular cartilage?
In our prior investigations using a canine model, an autol-
ogous chondrocyte-seeded type II collagen scaffold
cultured for 4 weeks prior to implantation into a defect inaCurrent address: Medtronic Spinal and Biologics, 2600 Sofamor
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1237the articular surface of the stiﬂe joint1 resulted in more re-
parative tissue and a greater percentage of hyaline cartilage
after 15 weeks, compared to a chondrocyte-seeded scaffold
cultured for only 12 h prior to implantation2. While the con-
structs cultured for 12 h and 4 weeks had different compo-
sitions and mechanical behaviors those parameters were
not quantitatively evaluated. Therefore, it was not possible
to correlate certain features of the make-up of the con-
structs with the in vivo ﬁndings.
Several approaches have been successfully employed for
the production of cartilaginous constructs with varying de-
grees of maturity (e.g., glycosaminoglycan, GAG, content)
in vitro. Numerous studies have demonstrated the effects
of growth factors individually3e5 and in combination6e8 on
chondrocytes in monolayer and three-dimensional (3-D) cul-
tures. One prior investigation showed a substantial increase
in the GAG content of chondrocyte-seeded type II collagen
scaffolds grown in serum-free medium supplemented with
ﬁbroblast growth factor (FGF)-2, compared to cultures with
no FGF-2 supplementation, after only 2 weeks in culture9.
Another recent investigation of chondrocyte-seeded type II
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regulate the rate of chondrogenesis in vitro by altering the
cross-link density of the scaffolds10. The study demon-
strated that the cross-link density of the scaffold signiﬁcantly
affected chondrogenesis in vitro. Scaffolds with low cross-
link densities, which underwent cell-mediated contraction,
displayed a substantially greater GAG density than scaffolds
of higher cross-link density, which did not contract10. In order
to prepare constructs of a particular diameter for implanta-
tion, allowance would have to be made for the amount a con-
struct would contract, in selecting the original diameter of the
scaffold to be seeded with cells.
One of the challenging aspects of the investigation of the
degree of maturity that a tissue-engineered construct
should have prior to implantation relates to the parameters
to employ for the evaluation of the maturity of the tissue-
engineered construct: morphological/histological, biochemi-
cal, and/or mechanical. To begin to address this issue we
selected the sulfated GAG density of tissue-engineered
cartilaginous constructs as one measure of their degree of
maturity, relative to the GAG density of native articular car-
tilage. The goal is to eventually implant constructs with
25%, 50%, and 75% the GAG density of native cartilage
into defects in an animal model. The objective of the current
study was to evaluate the GAG density and compressive
modulus of chondrocyte-seeded type II collagen scaffolds
using various combinations of cross-link density and time
in culture; caprine cells were used because a goat model
will be used for the in vivo evaluation.Materials and methodsTYPE II COLLAGENeGAG SCAFFOLD FABRICATIONSheets of the type II collagen scaffold, 2.5 mm in thickness, were pre-
pared from a 1% slurry of porcine type II collagen (Geistlich Biomaterials,
Wolhusen, Switzerland) in 0.001 N HCl using a freeze-drying protocol found
to generate scaffolds with porosity of about 90% and pores with a diameter of
approximately 200 mm10. Disks, 8 mm in diameter, punched from the sheets
were sterilized (and lightly cross-linked) by dehydrothermal treatment
(DHT)10. Additional cross-linking was produced with a water-soluble carbo-
diimide11,12. Matrices were immersed in a solution containing 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDAC, Sigma Chemical
Co., St. Louis, MO, USA) and N-hydroxysuccinimide (NHS, Sigma Chemical
Co., St. Louis, MO, USA) for 2 h10. Various EDAC:NHS molar ratios were
employed, relative to the carboxyl contained in the collagen scaffold
(1.2 mM COOH per mole of collagen)12. Five groups received EDAC treat-
ments and a sixth group was only cross-linked by DHT (Table I).
Relative cross-link density of the scaffolds (n¼ 2e4)10 was determined
indirectly by their swelling ratios, SRs13,14; the cross-link density varies
with the inverse of SR.CHONDROCYTE CULTURE, SEEDING OF THE SCAFFOLDS,
AND VOLUME MEASUREMENTSArticular cartilage was harvested from the stiﬂe joints of adult Spanish
goats immediately postmortem. Chondrocytes were isolated usingTable I
Cross-linking agent molar ratios employing EDAC and NHS. Ratios
are shown relative to the carboxyl contained in the collagen scaffold
MeanS.D.
Cross-link
group
Molar ratios SR (n)
EDAC NHS COOH
DHT only 0 0 1 8.18 2.49 (4)
EDAC1 1 1 5 7.36 0.67 (3)
EDAC1.5 2.5 1 5 5.73 0.29 (3)
EDAC2 5 2 5 5.30 0.12 (4)
EDAC2.5 10 4 5 5.06 0.44 (2)
EDAC3 10 4 1 4.36 0.33 (4)a previously published protocol10, and cultured separately. In a pilot study,
passage (P) 2 chondrocytes isolated from one goat were grown in scaffolds
with six cross-link densities for 2, 3, 4, and 6 weeks (n¼ 3). The goal was to
select scaffold cross-link densities and times in culture that would produce
constructs with approximately 25%, 50% and 75% the GAG density of
native articular cartilage. Considering the results of the pilot study, P3
chondrocyte-seeded scaffolds with two cross-link densities (EDAC1.5 and
EDAC2) were cultured for three time periods: 3, 5, and 9 weeks. Based
on the available P3 cells (Table II), a sample size of six was achieved using
Goat 1 cells to seed three groups, cells from Goat 2 to seed two groups,
and cells from Goat 3 to seed the sixth group of scaffolds. For the
EDAC1.5 groups, the experiment was conducted in quadruplicate
(n¼ 24), because the pilot data indicated that this treatment might be
the most promising to yield the widest range of GAG density.
The scaffolds were seeded with 4 106 cells and grown in chondrogenic
medium as previously described10.
The diameters of the cell-seeded matrices and unseeded controls were
measured at the end of the culture period using circular templates ranging
from 1 mm to 10 mm diameter in 0.5 mm increments. Thickness was
measured using a micrometer with a resolution of 0.01 mm. The volume of
the constructs was calculated from these dimensions.MECHANICAL TESTINGUnconﬁned compression testing was conducted to determine the equi-
librium modulus of elasticity, E, of cell-seeded and non-cell-seeded control
scaffolds (n¼ 6) and full-thickness (mean, 0.8 mm) samples of caprine ar-
ticular cartilage tissue (n¼ 3 plugs from ﬂat surfaces from one goat knee)
of about the same diameter as the scaffolds. A cylindrical polymethyl meth-
acrylate loading platen, 9.5 mm in diameter, was used in the test appara-
tus. Stress relaxation tests were conducted to steps of 2%, 4%, 6%, 8%,
10%, 15% and 20% engineering strain, with each step applied at a con-
stant rate over 5 s and held for a subsequent 300 s, based on pilot data
which showed that values at 300 s were within w5% of the values at
100 s. The compressive modulus was taken to be the slope of a linear
regression line ﬁt to the equilibrium stress and strain calculated at the com-
pletion of each step. Tests were accepted if the linear regression coefﬁ-
cient of determination was at least 0.9, as a check for test error such as
sample slip or tearing, which would affect the stressestrain relationship
(modulus). The multiple measurements indicated that the stressestrain
relationship was linear (free of strain-stiffening or softening) in most
samples, validating the calculation of modulus. Test elimination could
usually be traced to a visible tear or unusual slipping of a rounded sample
in the test chamber.BIOCHEMICAL ANALYSIS AND HISTOCHEMISTRY/
IMMUNOHISTOCHEMISTRYAt the termination of the cultures and the mechanical tests the constructs
were cut into half, for allocation of samples for determination of GAG content
using the dimethylmethylene blue dye assay15 and for Safranin-O histo-
chemical staining and type II immunohistochemistry10. Unseeded control
scaffolds and samples of goat articular cartilage were also analyzed for
GAG content. Cartilage was removed (down to the tidemark) from the two
sloping sides of the trochlea from one of the stiﬂe joints of two goats (for a to-
tal of four samples). Disks (4 mm in diameter) were punched from the sam-
ples which ranged in thickness from 0.6 mm to 0.9 mm.
As in prior immunohistochemical studies10, the scaffold material did not
stain with the antibody, likely due to the breakdown of the epitope in the
course of processing the material.STATISTICSA sample size of n¼ 6 was used for most of the analyses using
a power calculation based on detecting a signiﬁcant difference between
two groups of 30%, with a¼ 0.05 and b¼ 0.05 and a standard deviation
(SD) of 15%. P< 0.05 was set as the criterion of signiﬁcance for statistical
tests.Table II
Number of cells (millions)
Goat # Thawed cells P1 P2 P3
1 10.3 30 86.5 171
2 9.5 26.1 82 138
3 4.6 9.6 40 74.6
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The various cross-link protocols yielded a range of cross-
link densities reﬂected in the SRs (Table I).
As has been observed in previous work10, cell-seeded
constructs which were only lightly DHT cross-linked con-
tracted to less than 30% of their original diameter after
only 2 weeks. This contraction of the scaffolds was visible
after as little as 1 week in culture. The small size of some
scaffolds resulted in loss of a few samples in the pilotFig. 1. Micrographs of chondrocyte-seeded type II collagen scaffolds afte
EDAC2 group; and (d) EDAC3 group. The micrographs in (a)e(d) were st
(f) Micrographs of EDAC1.5 samples after 3 and 9 weeks, respectively
through the middle part of the disk-shaped scaffold. (e) Safranin-O and (experiment. Other lightly cross-linked samples were lost
owing to their disintegration in culture.HISTOLOGY AND IMMUNOHISTOCHEMISTRYThere was a notable reduction in size of the 3-week con-
structs related to their cross-link density [Fig. 1(aed)]. DHT-
treated scaffolds contracted to irregular spherical structures
only about 2 mm in diameter [Fig. 1(a)]. The DHT- and
EDAC1-treated constructs displayed folding of the scaffoldsr 3 weeks in culture: (a) DHT cross-linked; (b) EDAC1.5 group; (c)
ained with Safranin-O and taken at the same magniﬁcation. (e) and
, taken at the same magniﬁcation. (b)e(d) Planar sections made
f) type II collagen immunohistochemical stain (brown chromogen).
250
Week 2
1240 E. Pfeiffer et al.: Compressive modulus of cartilage engineered in type II collagen scaffoldsduring the process of contraction in the ﬁrst 3-week period
of culture; all of the EDAC2, EDAC2.5, and EDAC3 speci-
mens and many EDAC1.5 scaffolds remained in the disk
shape throughout the culture periods. Scaffolds with higher
cross-link densities retained more of the initial sponge-like
architecture of the scaffold [comparing Fig. 1(aed)].
Chondrogenesis was evident based on the characteristic
rounded morphology of cells located in lacunae [Fig. 1(e)],
histochemical staining of GAG using Safranin-O stain
[Fig. 1(aec), and (e)], and type II immunohistochemistry
[Fig. 1(f)]. Of note was the decrease in chondrogenesis
with increasing cross-link density [comparing Fig. 1(aed)].
For the EDAC1.5, EDAC2, and EDAC3 cross-link groups
there was an increase in the amount of tissue containing
GAG and type II collagen with time in culture. This was
less evident in the DHT group, because of the small size
of the constructs and substantial amount of cartilage found
by 3 weeks.
Also of note was the inverse relationship between the
degree of chondrogenesis and the presence of residual
scaffold, which could be distinguished in histological section
by its morphology. Little residual scaffold was found in the
DHT only samples [Fig. 1(a)] which displayed intense
GAG staining and a majority of cells of chondrocytic mor-
phology, whereas much of the initial type II collagen scaf-
fold appeared to remain in the EDAC3 group [Fig. 1(d)]
which displayed substantially less cartilage formation. In in-
dividual samples in the EDAC1.5 [Fig. 1(b)] and EDAC2
[Fig. 1(c)] groups, regions of cartilage formation with little
remaining scaffold could generally be found in the interior
portions of the samples with remaining scaffold found in
the peripheral regions which displayed no chondrogenesis.
While chondrogenesis was clearly evident in the scaffolds
in the less cross-linked groups, cells of a non-chondrocytic
phenotype were also present in the scaffolds of lower
cross-link density. Even though immunohistochemistry for
type I collagen was not performed, it was evident that
some must be present because the type II antibody did
not label all of the newly synthesized matrix. The ﬁbrous
appearance of the matrix in cartilaginous regions, including
some that stained positive for type II collagen [Fig. 1(f)], in-
dicated the presence of ﬁbrocartilage. The mixed make-up
of tissues (hyaline cartilage, ﬁbrocartilage and ﬁbrous
tissue) within individual constructs was a common ﬁnding.
Also of interest was the high cell number density in many
of the cartilaginous regions [Fig. 1(e)]. Some cells in these
hypercellular areas displayed pyknotic nuclei, and cell de-
bris could also be seen, suggesting the eventual reduction
in cell number.200
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Fig. 2. Pilot study comparing the effect of cross-link group and time in
culture on GAG content. GAG content (GAG/volume) is shown as
percent of that in native caprine articular cartilage (15.8 mg/mm3).The GAG/volume values for the four goat articular carti-
lage samples were: 3.3 mg/mm3 and 18.9 mg/mm3 for one
goat and 8.6 mg/mm3 and 12.7 mg/mm3 for the samples
from the second goat; compared to 27 mg/mm3 for native
adult bovine cartilage16. Interestingly, there was a strong in-
verse correlation between GAG density and sample thick-
ness (linear regression analysis; R2¼ 0.99). Our cartilage
samples included the superﬁcial zone which may have
had a decreased GAG content. The inverse correlation
might be explained, then, if the GAG-depleted superﬁcial
zone increased with increasing thickness, but this will re-
quire additional work to resolve. For the purposes of com-
parative analysis, the GAG content from the pilot
experiment was expressed per volume of the constructs
and presented relative to the average of the highest GAGdensity values for the two goats, 15.8 mg/mm3. Thus we
chose a conservative approach in estimating the GAG den-
sity of the native goat cartilage.
The GAG density of the tissue-engineered constructs
generally increased with decreasing cross-link density
(Fig. 2). There was no systematic increase in GAG density
with time in culture across all cross-link groups (Fig. 2). Of
note was the ﬁnding that selected constructs achieved
GAG densities substantially higher than native cartilage
after only 2 weeks in culture.
Based on the goal of producing constructs with approxi-
mately 25%, 50%, and 75% the GAG density of native car-
tilage, it was decided to employ the EDAC1.5 and EDAC2
cross-link protocols for 3, 5, and 9 weeks. For these two
cross-link densities, there was a signiﬁcant ﬁve-fold in-
crease in total GAG content with time from about 150 mg
at 3 weeks to 750 mg at 9 weeks [Fig. 3(a)]. The total
GAG content was comparable for the two cross-link groups
at each of the three time periods [Fig. 3(a)]. Three-factor
analysis of variance (ANOVA) revealed a signiﬁcant effect
of time on GAG content (P< 0.0001, power¼ 1), but no ef-
fect of cross-link treatment (P¼ 0.27) or of animal source of
cells (P¼ 0.07, power¼ 0.51). Fisher’s protected least
squares differences (PLSD) post hoc testing showed that
the differences in GAG content between time periods
were signiﬁcant. Two-factor ANOVA performed on the
EDAC1.5 group demonstrated that there was no effect of
quadruplicate set on GAG content, as would be expected.
Of note, however, was the effect of animal source of cells
on the GAG content for the EDAC1.5 data, with cells
from one of the animals resulting in 30e50% higher values
of GAG content after 5 and 9 weeks; two-factor ANOVA
(time and animal) revealed a signiﬁcant effect of animal
source of cells on GAG content (P¼ 0.0003, power¼
0.98).
There was a dramatic difference in the volumes of the
constructs prepared with these two cross-link protocols
[Table III; Fig. 3(b)]. The EDAC1.5 group was about 20%
of its original volume at week 3, while the EDAC2 group
remained at about 80% of its original value through the
9-week culture period. Three-factor ANOVA revealed signif-
icant effects of cross-link treatment and animal source of
cells on volume (both P< 0.0001, power¼ 1); there was
also a signiﬁcant effect of time on volume, but with a low
power (P¼ 0.04, power¼ 0.6). In analyzing the data for
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S.E.M. (n¼ 24 for the EDAC1.5 groups, and n¼ 6 for the EDAC2
groups).
1241Osteoarthritis and Cartilage Vol. 16, No. 10the EDAC1.5 group only, two-factor ANOVA (time and
quadruplicate set) showed no signiﬁcant difference in the
volumes of the constructs in the quadruplicate sets of
data at each of the three time periods.Non-cell-seeded control scaffolds were found to have
a GAG density of 0.14 0.09 mg/mm3 (meanSD; n¼ 4).
Owing to the large difference in the volumes of the
constructs there was a large difference in the GAG density
between the two cross-link groups [Fig. 3(c)], with the
EDAC1.5 constructs displaying a three-fold greater GAG
density than the EDAC2 group at 3 weeks, two-fold greater
at 5 weeks, and 2.5-fold greater at 9 weeks [at 9 weeks,
21.5 2.5, mean standard error of the mean (S.E.M.) vs
8.6 1.3 mg/mm3]. For both cross-link groups there was
an increase in GAG density with time [Fig. 3(c)]: the mean
value for the 3-week EDAC1.5 group was about 60% of
the native value of 15.8 mg/mm3, and the 5-week
EDAC1.5 samples exceeded that value.
Three-factor ANOVA revealed signiﬁcant effects of cross-
link treatment (P< 0.0001, power¼ 1), time (P¼ 0.0002,
power¼ 0.99), and animal source of cells (P¼ 0.035, but
with a low power¼ 0.63) on GAG density. Fisher’s PLSD
post hoc testing showed signiﬁcant differences in GAG den-
sity between weeks 3 and 5 (P¼ 0.005) and 3 and 9
(P< 0.0001), but no difference in GAG density between
weeks 5 and 9 (P¼ 0.15). In analyzing the data for the
EDAC1.5 group only, two-factor ANOVA (time and quadrupli-
cate set) showed no signiﬁcant difference in the GAG values
in the quadruplicate samples at each of the three time periods.COMPRESSIVE MODULUSNon-cell-seeded, hydrated scaffolds in the EDAC1.5 cross-
linking group had a modulus of 0.88 0.38 kPa (meanSD;
n¼ 4) while scaffolds in the EDAC2 group had a modulus of
1.45 0.84 kPa (n¼ 3). The modulus of native caprine
articular cartilage was 314 221 kPa (mean SD; n¼ 3).
The values for compressive moduli for the less cross-
linked group (EDAC1.5) were higher than the values for
the EDAC2 group at each of the three time periods of
culture [Fig. 4(a)]. After 9 weeks the EDAC1.5 modulus
was three-fold higher than that of the EDAC2 group
(w31.5 3 kPa, mean S.E.M., vs 10.7 5 kPa). The mod-
uli of each cross-link group increased with time in culture
with the EDAC1.5 group increasing ﬁve-fold (6.1 2 kPa
to 31.5 5 kPa) from 3 to 9 weeks [Fig. 4(a)]. Even the
highest mean value of 31.5 kPa was only 10% of the native
modulus, despite the fact that the GAG density for this
group was 140% of the native value.
Two-factor ANOVA revealed signiﬁcant effects of cross-
link treatment (P¼ 0.001, power¼ 0.94) and time (P¼
0.0002, power¼ 0.991) on modulus. Fisher’s PLSD post
hoc testing showed that the differences between individual
cross-link groups and among all time points were signiﬁ-
cant. For the EDAC1.5 group, two-factor ANOVA (time
and quadruplicate set) showed a signiﬁcant effect of time
(P< 0.0001, power¼ 1) but not of quadruplicate samples
(P¼ 0.06, power¼ 0.69) on modulus . Two-factor ANOVA
(time and animal) revealed a signiﬁcant effect of time on
modulus (P< 0.0001, power¼ 1), but not of animal source
of cells (P¼ 0.35).
The relationship between GAG density (mg/mm3), rGAG,
and modulus (kPa), EComp, from linear regression analysis
[Fig. 4(b)], was:
EComp ¼ 1 rGAG
P < 0:0001;R2 ¼ 0:6
where the S.E.M. for the coefﬁcient was 0.1.
Table III
Dimensions of the constructs cross-linked with the EDAC1.5 and EDAC2 carbodiimide protocols (mm); mean S.E.M. (n)
EDAC1.5 EDAC2
Thickness Diameter Thickness Diameter
Initial 1.8 0.2 (4) 8.3 0.2 (4) 2.1 0.2 (3) 8.3 0.8 (3)
3 Weeks 2 0.1 (24) 3.6 0.3 (24) 1.8 0.2 (6) 7.2 0.4 (6)
5 Weeks 2.5 0.1 (20) 4.1 0.3 (20) 1.9 0.1 (6) 7.1 0.4 (6)
9 Weeks 2.7 0.1 (24) 4.2 0.2 (24) 2.2 0.1 (6) 7.0 0.4 (6)
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This study showed that the cross-link density of the type II
collagen scaffolds was a principal determinant of the GAG
density of chondrocyte-seeded constructs, thus supporting
earlier ﬁndings10. A notable ﬁnding was that the GAG
density of some of the constructs substantially exceeded
the value for goat articular cartilage after only a few weeks
of culture. Recent work17 growing primary 1-week old calf
chondrocytes in scaffold free-culture also found GAG
values which exceeded that of native (bovine) cartilage:
two-fold at 4 weeks, and then decreasing to two-thirds at
12 weeks. In the pilot study there was no systematic change
of GAG density with time across all groups, while in the0
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Fig. 4. (a) Compressive modulus from each time point and cross-
link combination. Mean S.E.M. (n¼ 24 for the EDAC1.5 groups,
and n¼ 6 for the EDAC2 groups). Native caprine articular cartilage
had a modulus of 314 221 kPa (meanSD; n¼ 3). (b) Scaffold
compressive modulus plotted against GAG density, including all
samples. The line shows the linear regression ﬁt. E1.5, EDAC1.5;
E2, EDAC2.follow-up work with the EDAC1.5 and EDAC2 groups there
was an increase with time. This might be explained in the
groups with lower cross-link density (viz., DHT and
EDAC1) by the substantial amount of cartilage that had
already formed in the constructs after only 2 weeks.
The increased GAG density in the less cross-linked, more
contracted scaffolds was not due to a densiﬁcation of the
GAG that had already formed, because the majority of the
contraction occurred before most of the GAG production.
Also of importance is that the difference in the GAG density
among the constructs was associated with a phenotypic dif-
ference in the cells. Cells in the constructs which contracted
and had a high GAG density displayed the chondrocytic
phenotype of rounded cells in lacunae, whereas cells in
constructs with a low GAG density were not chondrocytic
in appearance. It has been well-documented that isolated
chondrocytes de-differentiate during monolayer culture18
associated with their adoption of a ﬂattened morphology,
particularly in the presence of FGF-26. These cells re-differ-
entiate to chondrocytes in vitro under conditions which allow
(or perhaps force) them to assume a spherical shape19e21.
The fact that individual constructs can be populated by both
re-differentiated and de-differentiated chondrocytes, which
may be synthesizing various types of GAG at different
rates, complicates investigations of the effects of cross-
link density and contracture on the rate of cartilage-speciﬁc
GAG production.
Contraction of the scaffolds has previously been attrib-
uted to a-smooth muscle actin expression22. The contrac-
ture of the more compliant EDAC1.5 scaffolds resulted in
an increase in cell number density in selected regions of
the construct10. This ﬁnding recalls the ‘‘condensation’’ of
mesenchymal progenitor cells necessary for the develop-
ment of cartilage in vivo23e25 and in ‘‘micro-mass’’
cultures26. Contracture-facilitated aggregation of cells in
the scaffolds, increasing the packing density, may have
induced chondrocyte expression by increasing cellecell
contacts27e31 and/or by favoring a rounded morphology32.
Once cells re-differentiated in the contracted scaffolds,
contracture may have favored chondrogenesis by facilitat-
ing the retention of newly synthesized matrix molecules
within the collapsed pores of the constructs10. The scaf-
folds of higher cross-link density and stiffness, resisting
cell-mediated contraction, may have inhibited/delayed
the chondrocytic re-differentiation of the cells by providing
an environment permissive of the maintenance of a ﬂat-
tened/elongated morphology of the de-differentiated
chondrocytes.
Also of interest was the ﬁnding that the greater the de-
gree of chondrogenesis the lesser the amount of residual
scaffold10. The increased rate of scaffold degradation asso-
ciated with cartilage formation, i.e., perhaps to be consid-
ered a remodeling process, may have been due to
enzymes synthesized by the re-differentiated chondrocytes
acting on the scaffolds of lower cross-link density.
1243Osteoarthritis and Cartilage Vol. 16, No. 10Cross-link density and culture-time combinations could
be found to engineer constructs with mean GAG densities
from 20% to 100% of normal caprine GAG density, for con-
structs ranging in diameter from 3 mm to 7 mm. The results
provide a basis for determining the cross-link density and
time in culture required to produce constructs of a particular
size and GAG density for implantation. While cartilaginous
constructs may be formed in scaffold free-cultures33,34,
the use of the type II collagen scaffold may provide a wider
range of dimensions of the construct and shorter culture
times.
The compressive modulus of natural caprine articular car-
tilage reported in this study (314 kPa) compares with values
from 300 kPa to 800 kPa for bovine articular cartilage tested
under unconﬁned compression35. The compressive modu-
lus of selected constructs reached about 25% of normal.
The highest mean modulus was, however, 10% of the nor-
mal value, even though the GAG density for the group was
about 140% of the native value. Unconﬁned compression
moduli reported for other chondrocyte-seeded scaffolds in-
clude: 12 kPa after 28 days in culture for a biodegradable
elastomer, poly(1,8-octanediol citrate), construct36; and
100 kPa for a hyaluronan scaffold37 with selected cell-
seeding densities and times in culture.
There was only a modest correlation between compres-
sive modulus and GAG density, reﬂected in the R2 value of
0.60. This is understandable in the light of the known
contributions of type II collagen, water content, and other
matrix molecules, and microstructure, to the mechanical
behavior of articular cartilage38. Prior work39 demonstrated
a coefﬁcient of determination of about 0.40 for the correla-
tion between GAG content and equilibrium modulus for
human articular cartilage samples obtained from several
joints; a multivariate analysis of the correlation of the
GAG, water, and hydroxyproline contents with modulus
revealed R2 values greater than 0.80, with GAG being
the most signiﬁcant factor. Other studies correlating GAG
content and unconﬁned compressive modulus for chondro-
cyte-seeded scaffolds found: R2¼ 0.61 for calf chondro-
cyte-seeded agarose hydrogels40; and R2¼ 0.36 for adult
bovine chondrocyte-seeded non-woven hyaluronan
ﬂeeces37.
The moduluseGAG relationship for tissue-engineered
constructs can be confounded by the non-uniformity of
the tissue in the scaffolds. Well-developed cartilage could
be found in the interior regions of constructs which dis-
played residual scaffold in the periphery of the samples.
Moreover, time in culture and maturation/remodeling of
the constructs can also affect the relative modulus and
GAG values. The conﬁned compression modulus of calf
chondrocyte-seeded non-woven polyglycolic acid ﬁber
meshes41 increased from 20% of normal for 3-month con-
structs of native GAG content to the normal values (about
1000 kPa) for 7-month constructs with a GAG content
120% of the native value.
Results of the current study provide a basis for future
work investigating the effects of the degree of maturation
of tissue-engineered cartilaginous constructs on cartilage
repair in vivo. It will be useful in future studies to investigate
other measures of construct maturity, including collagen
content, to relate to the mechanical behavior of the
constructs and their contribution to cartilage repair in vivo.Conﬂict of interest
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